Public-private partnerships in blindness prevention: Reaching beyond the eye

Eye

Volumn 19, Issue 10, 2005, Pages 1050-1056

  Molyneux, David H ^a   Nantulya, V ^b  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b TUBERCULOSIS AND MALARIA   (Switzerland)

Author keywords

Albendazole; Filariasis; Ivermectin; Malaria; Millennium development goals; Onchocerciasis

Indexed keywords

ALBENDAZOLE; AZITHROMYCIN; HEMOGLOBIN; IVERMECTIN; PRAZIQUANTEL; RETINOL; REVECTINA;

ACADEMIC ACHIEVEMENT; ANEMIA; ARTICLE; ASCARIASIS; ASCARIS; BRAIN DISEASE; BRAIN MALARIA; COMMUNITY CARE; DISEASE SEVERITY; ECTOPARASITE; FEVER; FILARIASIS; GROWTH RATE; HEALTH PROGRAM; HOOKWORM; HUMAN; INFECTION CONTROL; LOA LOA; LYMPHATIC SYSTEM INFECTION; MALARIA; MORBIDITY; NONHUMAN; NUTRITIONAL STATUS; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PARASITE TRANSMISSION; PARASITE VECTOR; PUBLIC HEALTH SERVICE; SCHISTOSOMIASIS; SIMULIUM; TRACHOMA;

EID: 29244431615     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6701961     Document Type: Article

References (42)

1. Mectizan and Onchocerciasis: A decade of accomplishment and prospects for the future; the evolution of a drug into a development concept. Ann Trop Med Parastiol 1998; 92(Suppl 1): 1-179.
2. Benton B, Bump J, Seketeli A, Liese B. Partnership and promise: evolution of the African river-blindness campaigns. Ann Trop Med Parasitol 2002; 96(Suppl 1): S5-S14.
3. Frost L, Reich MR, Fujisaki T. A partnership for ivermectin: Social worlds and boundary objects. In: Reich MR (ed). Public Private Partnerships for Public Health. Harvard University Press: Cambridge, MA. 2002, pp 87-113 (Chapter 5).
4. Widdus R. Public-private partnerships for health: Their main targets, their diversity, and their future directions. Bull World Health Organ 2001; 79(8): 713-720.
5. Reich MR. Public-Private Partnerships for Public Health. In: Reich MR (ed). Harvard University Press: Cambridge, MA. pp 1-18 (Chapter 1).
6. Dadzie Y, Neira M, Hopkins D. Final report of the conference on the eradicability of onchocerciasis. Filaria J 2003; 2(1): 2.
7. Peters DH, Phillips T. Mectizan donation program: Evaluation of a public-private partnership. Trop Med Int Health 2004; 9(4): A4-A15.
8. Molyneux DH, Bradley M, Hoerauf A, Kyelem D, Taylor MJ. Mass drug treatment for lymphatic filariasis and onchocerciasis. Trends Parasitol 2003; 19(11): 516-522.
9. Sékétéli A. APOC at mid-point: So far so good. Ann Trop Med Parasitol 2002; 96(Suppl 1): S3-S4.
10. Burnham G, Mebrahtu T. The delivery of ivermectin (Mectizan). Trop Med Int Health 2004; 9(Suppl): A26-A44.
11. Drameh P, Richards FO, Cross C, Etya'ale DE, Kassalow JS. Ten years of NGDO action against river blindness. Trend Parasitol 2002; 18(9): 378-380.
12. Little MP, Breitling LP, Basanez MG, Alley ES, Boatin B. Association between microfilarial load and excess mortality in onchocerciasis: An epidemiological study. Lancet 2004; 363: 1514-1521.
13. Heukelbach J, Winter B, Wicke T, Muehlen M, Albrecht S, de Oliveira SFA et al. Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population. Bull World Health Organ 2004; 82: 563-569.
14. Ottesen EA, Ismail MM, Horton J. The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitol Today 1999; 15(9): 382-386.
15. Molyneux DH, Nantulya V. Linking disease control programmes in rural Africa: A pro-poor strategy to reach Abuja targets and millennium development goals. BMJ 2004; 328: 1129-1132.
16. Akogun OB, Akogun MK, Audu Z. Community perceived benefits of ivermectin treatment in northeastern Nigeria. Soc Sci Med 2000; 50: 1451-1456.
17. Amazigo UV, Brieger WR, Katabarwa M, Akogun O, Ntep M, Boatin B et al. The challenges of community-directed treatment with ivermectin (CDTI) within the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol 2002; 96(Suppl 1): S41-S58.
18. Amazigo UV, Obono M, Dadzie KY, Remme J, Jiya J, Ndyomugyenyi R et al. Monitoring community-directed treatment programmes for sustainability: lessons from the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol 2002; 96(Suppl 1): S75-S92.
19. Homeida M, Braide E, Elhassan E, Amazigo UV, Liese B, Benton B et al. APOC's strategy of community-directed treatment with ivermectin (CDTI) and its potential for providing additional health services to the poorest populations. Ann Trop Med Parasitol 2002; 96(Suppl 1): S93-S104.
20. Webbe G. The onchocerciasis control programme. Trans R Soc Trop Med Hyg 1992; 86(2): 113-114.
21. Lucas AO. Public-private partnerships: Illustrative examples. In: Reich MR (ed). Public Private Partnerships for Public Health. Harvard University Press: Cambridge, MA, 2002, pp 19-39 (Chapter 2).
22. Reich MR. Introduction: Public-private partnerships for public health. In: Reich MR (ed). Public-Private Partnerships for Public Health. Harvard University Press: Cambridge, MA, 2002, pp 1-18 (Chapter 1).
23. Samba E. The Onchocerciasis Control Programme in West Africa: An Example of Effective Public Health Management. World Health Organization: Geneva, Switzerland, 1994.
24. Remme JH. The African programme for onchocerciasis control: Preparing to launch. Parasitol Today 1995; 11: 403-406.
25. Vercruysse J. Macrocyclic Lactones in Antiparasitic Therapy. CABI Publishing: Wallingford, 2002; 448.
26. Abiose A, Homeida M, Liese B, Molyneux D, Remme H. Onchocerciasis control strategies. Lancet 2000; 356(9240): 1523-1524.
27. Kyelem D, Sanou S, Boatin B, Medlock J, Coulibaly S, Molyneux DH. Impact of long-term ivermectin (Mectizan) on Wuchereria bancrofti and Mansonella perstans infections in Burkina Faso: Strategic and policy implications. Ann Trop Med Parasitol 2003; 97(8): 827-838.
28. Molyneux DH, Neira M, Liese B, Heymann D. Royal Society of Tropical Medicine and Hygiene Meeting at Manson House, London, 20 January 2000. Elimination of lymphatic filariasis as a public health problem. Lymphatic filariasis: Setting the scene for elimination. Trans R Soc Trop Med Hyg 2000; 94: 589-591.
29. Brengues J. La Filariose de Bancroft en Afrique de L'ouest. Mémoires ORSTOM 1975; 79: 7-295.
30. Borsboom GJ, Boatin BA, Nagelkerke NJ, Agoua H, Akpoboua KL, Alley EW et al. Impact of ivermectin on onchocerciasis transmission: Assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa. Filaria J 2003; 2: 8.
31. Gardon J, Gardon-Wendel N, Demanga-Ngangue, Kamgno J, Chippaux JP, Boussinesq M. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 1997; 350(9070): 18-22.
32. Thomson MC, Obsomer V, Dunne M, Connor SJ, Molyneux DH. Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa. Lancet 2000a; 356: 1198.
33. Thomson MC, Obsomer V, Kamgno J, Gardon J, Wanji S, Takougang I et al. Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control. Filaria J 2004; 3(1): 7.
34. Takougang I, Meremikwu M, Wanji S, Yenshu EV, Aripko B, Lamlenn SB et al. Rapid assessment method for prevalence and intensity of Loa loa infection. Bull World Health Organ 2002; 80: 852-858.
35. Taylor HR, Duke BOL, Munoz BC. The selection of communities for treatment of onchocerciasis with ivermectin. Trop Med Parasitol 1992; 43: 267-270.
36. Ngoumou P, Walsh JF, Mace JM. A rapid mapping technique for the prevalence and distribution of onchocerciasis: A Cameroon case study. Ann Trop Med Parasitol 1994; 88(5): 463-474.
37. Molyneux DH, Zagaria N. Lymphatic filariasis elimination: Progress in global programme development. Ann Trop Med Paras 2002; 96(Suppl 2): S15-S40.
38. Stephenson LS, Holland CV, Ottesen EA. Controlling intestinal helminths while eliminating lymphatic filariasis. Parasitology 2000; 121(Suppl 2000): 173.
39. Miguel E, Kremer M. Worms: Identifying impacts on education and health in the presence of treatment externalities. Econometrica 2004; 72(1): 159-217.
40. Spiegel A, Tall A, Raphenon G, Trape JF, Pierre Druilhe. Increased frequency of malaria attacks insubjects co-infected by intestinal worms and Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 2003; 97: 198-199.
41. Le Hesran JY, Akiana J, Ndiaye el HM, Dia M, Senghor P, Konate L. Severe malaria attack is associated with high prevalence of Ascaris lumbricoides infection among children in rural Senegal. Trans R Soc Trop Med Hyg 2004; 98(7): 397-399.
42. Crompton DWT. The public health importance of hookworm disease. Parasitology 2000; 121: S39-S50.